M. Delcommenne et al., PHOSPHOINOSITIDE-3-OH KINASE-DEPENDENT REGULATION OF GLYCOGEN-SYNTHASE KINASE-3 AND PROTEIN-KINASE B AKT BY THE INTEGRIN-LINKED KINASE/, Proceedings of the National Academy of Sciences of the United Statesof America, 95(19), 1998, pp. 11211-11216
Integrin-linked kinase (ILK) is an ankyrin-repeat containing serine-th
reonine protein kinase capable of interacting with the cytoplasmic dom
ains of integrin beta 1, beta 2, and beta 3 subunits, Overexpression o
f ILK in epithelial cells disrupts cell-extracellular matrix as well a
s cell-cell interactions, suppresses suspension-induced apoptosis (als
o called Anoikis), and stimulates anchorage-independent cell cycle pro
gression. In addition, ILK induces nuclear translocation of beta-caten
in, where the latter associates with a T cell factor/lymphocyte enhanc
er-binding factor 1 (TCF/LEF-1) to form an activated transcription fac
tor. We now demonstrate that ILK activity is rapidly, but transiently,
stimulated upon attachment of cells to fibronectin, as well as by ins
ulin, in a phosphoinositide-3-OH kinase [Pi(3)K]-dependent manner. Fur
thermore, phosphatidylinositol(3,4,5)trisphosphate specifically stimul
ates the activity of ILK irt vitro, and in addition, membrane targette
d constitutively active Pi(3)K activates ILK in vivo. We also demonstr
ate here that ILK is an upstream effector of the Pi(3)K-dependent regu
lation of both protein kinase B (PKB/AKT) and glycogen synthase kinase
3 (GSK-3), Specifically, ILK can directly phosphorylate GSK-3 in vitr
o and when stably, or transiently, overexpressed in cells can inhibit
GSK-3 activity, whereas the overexpression of kinase-deficient ILK enh
ances GSK-3 activity. In addition, kinase-active ILK can phosphorylate
PKB/AKT on serine-473, whereas kinase-deficient ILK severely inhibits
endogenous phosphorylation of PKB/AKT on serine-473, demonstrating th
at ILK is involved in agonist stimulated, Pi(3)K-dependent, PKB/AKT ac
tivation. ILK is thus a receptor-proximal effector for the Pi(3)K-depe
ndent, extracellular matrix and growth factor mediated, activation of
PKB/AKT, and inhibition of GSK-3.